Japan colorectal tumor prevention study: clinical trial by low-dose aspirin (J-CAPP Study II)

ABSTRACT: Interventions: Medicate Primary outcome(s): The primary endpoint is set as the incidence of newly diagnosed colorectal Index Lesion (adenomas >= 10 mm in diameter, adenomas with high-grade dysplasia, or invasive cancer) during 4 years observation excluding the first-year observation. Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose

DISEASE(S): Patients With Colorectal Tumor (adenoma, Carcinoma In Situ)

PROVIDER: 2615273 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR